CINECA IRIS Institutional Research Information System

VIRDIS, AGOSTINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.467
AS - Asia 10.585
EU - Europa 6.688
SA - Sud America 1.734
Continente sconosciuto - Info sul continente non disponibili 563
AF - Africa 363
OC - Oceania 17
Totale 43.417
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.834
SG - Singapore 3.236
CN - Cina 2.954
IT - Italia 1.956
HK - Hong Kong 1.903
BR - Brasile 1.456
SE - Svezia 948
VN - Vietnam 899
DE - Germania 808
BG - Bulgaria 659
TR - Turchia 488
CA - Canada 478
GB - Regno Unito 436
FI - Finlandia 397
RU - Federazione Russa 370
FR - Francia 367
UA - Ucraina 283
KR - Corea 230
IN - India 211
JP - Giappone 138
CI - Costa d'Avorio 137
CH - Svizzera 102
AR - Argentina 95
BD - Bangladesh 89
IQ - Iraq 67
NL - Olanda 63
MX - Messico 62
ZA - Sudafrica 59
PK - Pakistan 55
ID - Indonesia 54
ES - Italia 49
BE - Belgio 48
EC - Ecuador 41
PL - Polonia 39
CO - Colombia 38
AT - Austria 37
UZ - Uzbekistan 37
SA - Arabia Saudita 33
VE - Venezuela 31
PY - Paraguay 30
SN - Senegal 28
MA - Marocco 22
PH - Filippine 22
TN - Tunisia 22
JM - Giamaica 20
CR - Costa Rica 19
GR - Grecia 19
IE - Irlanda 18
CL - Cile 17
DZ - Algeria 17
BJ - Benin 16
JO - Giordania 15
NG - Nigeria 15
IL - Israele 14
KE - Kenya 14
MY - Malesia 14
UY - Uruguay 14
AE - Emirati Arabi Uniti 13
AU - Australia 12
EG - Egitto 12
NP - Nepal 12
TT - Trinidad e Tobago 12
TH - Thailandia 11
KG - Kirghizistan 10
OM - Oman 10
BH - Bahrain 9
RS - Serbia 9
AZ - Azerbaigian 8
DK - Danimarca 8
KZ - Kazakistan 8
RO - Romania 8
HN - Honduras 7
LB - Libano 7
LT - Lituania 7
NI - Nicaragua 7
AL - Albania 6
CZ - Repubblica Ceca 6
GT - Guatemala 6
HR - Croazia 6
PT - Portogallo 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
EU - Europa 5
HU - Ungheria 5
LV - Lettonia 5
PE - Perù 5
PS - Palestinian Territory 5
BA - Bosnia-Erzegovina 4
ET - Etiopia 4
KH - Cambogia 4
NZ - Nuova Zelanda 4
SV - El Salvador 4
AM - Armenia 3
BN - Brunei Darussalam 3
EE - Estonia 3
GH - Ghana 3
LK - Sri Lanka 3
MD - Moldavia 3
MK - Macedonia 3
PA - Panama 3
Totale 42.802
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.389
Ashburn 2.200
Singapore 1.895
Hong Kong 1.870
Houston 1.749
Fairfield 1.713
Ann Arbor 1.687
San Jose 1.125
Chandler 1.088
Santa Clara 1.012
Dallas 824
Seattle 742
Sofia 657
Shanghai 646
Beijing 628
Wilmington 591
Cambridge 570
New York 510
Serra 478
Council Bluffs 455
Milan 381
Ottawa 366
Jacksonville 344
Boardman 342
Princeton 291
Hefei 279
Izmir 277
Los Angeles 275
Lawrence 272
Medford 244
Lauterbourg 240
Nanjing 227
Seoul 223
Ho Chi Minh City 216
Munich 193
Des Moines 173
Hanoi 154
Istanbul 151
Abidjan 137
Helsinki 128
Florence 125
Frankfurt am Main 124
Redondo Beach 123
Tokyo 119
Buffalo 118
Pisa 116
São Paulo 116
Nanchang 108
San Diego 102
Dong Ket 98
Lancaster 97
Dearborn 89
Bern 84
Boulder 82
The Dalles 68
Columbus 65
London 65
Falls Church 59
Kunming 59
Chicago 56
Ogden 54
Rome 53
Shenyang 50
Atlanta 47
Jüchen 47
Rio de Janeiro 47
Brussels 44
Jinan 44
Redwood City 44
Tianjin 43
Belo Horizonte 39
Changsha 39
Turku 39
Nuremberg 37
Washington 37
Phoenix 36
Amsterdam 35
Hebei 35
Tashkent 35
Da Nang 34
San Francisco 32
Brasília 31
Fuzhou 31
Montreal 30
Pune 30
Toronto 29
Dakar 28
Brooklyn 27
Norwalk 27
Saint Petersburg 27
Vienna 27
Warsaw 27
Baghdad 26
Salt Lake City 26
Hangzhou 25
Jakarta 25
Auburn Hills 23
Jiaxing 23
Orem 23
Curitiba 22
Totale 30.993
Salva come PNG Salva come JPEG
Nome #
Association Between Blood Pressure Variability, Cardiovascular Disease And Mortality In Type 2 Diabetes: A Systematic Review And Meta-Analysis 475
Identification of a cytochrome P450-2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients 331
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 311
Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers 279
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 276
Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension. 254
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 236
Combination therapy with lercanidipine and enalapril reduced central blood pressure augmentation in hypertensive patients with metabolic syndrome 231
Effect of verapamil, trandolapril and their combination on vascular function and structure in essential hypertensive patients. 229
Cigarette Smoking and Hypertension 224
Hemodynamic and Metabolic-Inflammatory Phenotyping Across the Cardiac Index Spectrum in Moderate and Severe Tricuspid Regurgitation: Prognostic Implications 218
Endothelial dysfunction in hypertension: Pathophysiological mechanism or marker of cardiovascular risk? 215
Device-based therapies for resistant hypertension. 215
Obesity in the childhood: a link to adult hypertension 212
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 212
Aging and hypertension. What about the endothelium? 211
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 207
Inducible Nitric Oxide Synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats 207
Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes. 206
Cholecalciferol administration blunts the systemic renin-angiotensin system in essential hypertensives with hypovitaminosis D. 205
Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy 200
Aging Modulates the Influence of Arginase on Endothelial Dysfunction in Obesity 200
Circulating mitochondrial DNA signature in cardiometabolic patients 198
The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients 198
Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women 194
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 194
Adenosine and the vascular tissue renin-angiotensin system in the forearm of essential hypertensive patients 193
Adenosine causes the release of active renin and angiotensin II in the coronary circulation of patients with essential hypertension 192
Spironolactone improves angiotensin-induced vascular changes and oxidative stress 191
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 191
Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma 190
Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients 186
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 185
Different Impact of Essential Hypertension on Structural and Functional Age-Related Vascular Changes 184
Donepezil improves vascular function in a mouse model of Alzheimer's disease 184
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 182
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 182
VASORELAXING EFFECTS OF H2S IN RAT MESENTERIC ARTERIES 180
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice 180
Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients 180
Vascular inflammation: a role in vascular disease in hypertension? 179
Chronic Treatment With Long-Acting Nifedipine Reduces Vasoconstriction to Endothelin-1 in Essential Hypertension. Hypertension 179
Adenosine causes angiotensin II release in human forearm arterioles. 179
A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke 178
Nitric oxide modulates tissue plasminogen activator release in normotensive subjects and hypertensive patients. 178
Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension 178
Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients 177
Inhibition of mitogen-activated protein/extracellular signal-regulated kinase improves endothelial function and attenuates Ang II-induced contractility of mesenteric resistance arteries from spontaneously hypertensive rats 176
Hypertension and cardiometabolic risk factors. 176
Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure 175
Hypertension causes premature aging of endothelial function in humans 175
Low birth weight and insulin resistance: can capillary recruitment predict hypertension development? 174
Menopause is associated with endothelial dysfunction in women 174
Adenosine activates a vascular renin-angiotensin system in hypertensive subjects. 174
Forearm vasodilation to acetylcholine is increased by potassium in essential hypertensive patients 173
Aging Modulates the Influence of Arginase on Endothelial Dysfunction in Obesity 173
Microvascular Endothelial Dysfunction in Patients with Obesity 173
Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension 173
Endothelial function assessment in complicated hypertension 172
Angiotensin II and sympathetic activity in sodium-restricted essential hypertension. 172
Antihypertensive drugs and reversing of endothelial dysfunction in hypertension 170
Vascular reactivity in patients with undifferentiated connective tissue diseases 169
Ventricular and vascular stiffening in aging and hypertension 169
Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy 168
Ghrelin restores nitric oxide availability in resistance circulation of essential hypertensive patients: role of NAD(P)H oxidase. 167
Endothelial function in hypertension. Evidences in humans. 166
ROLE OF NAD(P)H OXIDASE ON VASCULAR ALTERATIONS IN ANGIOTENSIN II-INFUSED MICE 166
Vascular dysfunction in a mouse model of rett syndrome and effects of curcumin treatment. 166
Endothelial function in hypertension 165
Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction 164
Microvascular endothelial dysfunction in obesity and hypertension. 164
Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients 163
The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors 163
Endothelial dysfunction as a target for prevention of cardiovascular disease 163
Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients. 163
Systemic inflammation and endothelial dysfunction in patients with Hashimoto’s thyroiditis and subclinical hypothyroidism 162
Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension 162
Effects of wine and grape polyphenols on blood pressure, endothelial function and sympathetic nervous system activity in treated hypertensive subjects 162
Lack of correlation between microalbuminuria and endothelial function in essential hypertensive patients. 161
Cutaneous vasodilation to acetylcholine in patients with essential hypertension 161
Vascular renin-angiotensin system and sympathetic nervous system activity in human hypertension. 161
The renal resistive index is associated with microvascular remodeling in patients with severe obesity 160
Human endothelial dysfunction: EDCFs 160
Inflammation and Vascular Ageing: From Telomeres to Novel Emerging Mechanisms 160
Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension 159
Blood pressure and vascular alterations with growth in childhood. 159
Oxidative Stress and Vascular Damage in Hypertension: Role of Angiotensin II 159
Microvascular endothelial dysfunction in human obesity: role of TNF-α 159
Endothelium dependent forearm vasodilation is reduced in normotensives with familial history of hypertension. 158
Mild hypothyroidism anticipates and accelerates age-related endothelial dysfunction in rat mesenteric small arteries: role of inducibile NO synthase 158
C-Reactive Protein and Hypertension: is there a causal relationship? 156
Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women 155
Central blood pressure, arterial stiffness, and wave reflection: New targets of treatment in essential hypertension 155
Effect of potassium on vasodilation to acetylcholine in essential hypertension. 154
Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of iNOS and oxidative stress 154
Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients 154
The eye and the heart 154
Hypertension in the elderly: an evidence-based review. 153
Tissue-type plasminogen activator release in healthy subjects and hypertensive patients - Relationship with beta-adrenergic receptors and the nitric oxide pathway 152
Age- and Sex-Specific Reference Values for Media/Lumen Ratio in Small Arteries and Relationship With Risk Factors 152
Totale 18.672
Salva come PNG Salva come JPEG
Categoria #
all - tutte 128.954
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.954
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.865 0 181 55 176 532 401 100 184 131 143 142 820
2022/20233.112 384 324 200 276 337 437 14 264 585 31 220 40
2023/20242.317 229 227 277 140 339 467 104 58 52 47 87 290
2024/20258.794 60 344 142 442 690 918 770 532 875 1.217 1.055 1.749
2025/20269.729 559 1.209 1.193 923 1.044 935 1.381 485 566 826 328 280
2026/20271.507 458 1.049 0 0 0 0 0 0 0 0 0 0
Totale 43.417